...PIK3CA, and ErbB2. The mutMap highlighted mutation coincidences occurring in ≥5% of patients, including TP53 with KRAS o...
...PIK3CA mutations (4.9%), five NRAS mutations (4.1%), four KIT mutations (3.3%), two PDGFRA mutations (1.6%), two ABL mut...
...PIK3CA gene in 4 of 18 human liposarcoma patients (22%). No PIK3CA mutations were identified in benign lipomas. Western ...
...PIK3CA (n=5). Clinically actionable somatic mutations were detected in 24/35 (69%) patients.,This study demonstrates tha...
...PIK3CA oncogenes was similar between interval cancer cases and controls.,Interval colon cancers are not distinguished by...
...PIK3CA and the methylation status of MLH1. Gender, age and localisation were significantly associated with certain types...
...PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha), and EML4 (echinoderm microtubule assoc...
...PIK3CA mutation status.,Moderate or high expression of PDK1 was observed in 213 of the 241 cases (88%). There was no cor...
...PIK3CA, PTEN, AKT1, and mTOR, were determined in 221 patients with stage T2 and T3 gastric cancer. Additionally, the act...
...PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) mutation frequency, and outcomes after ...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
